Unanswered questions on the safety of MDT-U - Reply

Gelijkaardige items

• Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach
  door: Rossilene Conceição da Silva Cruz, et al.
  Gepubliceerd in: (2018-06-01)
• Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR)
  door: Gerson Oliveira Penna, et al.
  Gepubliceerd in: (2024-03-01)
• Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT
  door: Emerith M. Hungria, et al.
  Gepubliceerd in: (2018-05-01)
• Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
  door: Gerson Oliveira Penna, et al.
  Gepubliceerd in: (2017-07-01)
• Statins: are any questions unanswered?
  door: Kearney, P, et al.
  Gepubliceerd in: (2006)